Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects

Bibani, Rashid H.; Tench, Christopher R.; George, Jithin; Manouchehrinia, Ali; Palace, Jacqueline; Constantinescu, Cris S.

doi:10.1016/j.msard.2012.03.004

Cited by 4 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This finding was consistent with the previous studies; however, it has been shown that a single injection of ethanol does not suffice to improve the neurological function (Figure 1). The neuroprotective effect of modafinil has been studied in animal models of neurodegenerative diseases (Bibani et al, 2012). Ueki et al reported that the ischemic striatal injury induced by the microinjections of ET-1 in the rat neostriatum is counteracted by modafinil (10, 30, and 100 mg/kg; i.p.)…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Behavioral Changes in Combination Therapy of Ethanol and Modafinil on rats Focal Cerebral Ischemia

Abbasi

Mousavizadeh

Shabani

et al. 2020

Basic Clin. Neurosci. J.

View full text Add to dashboard Cite

Ethanol is considered as an effective agent in reducing brain stroke injury. In this study, we assessed the effects of modafinil along with ethanol as a combination therapy on behavioral function in Wistar rats. Methods: The right Middle Cerebral Artery Occlusion (MCAO) was performed and the rats were divided into nine groups (n=8 per group). The animal groups in this study were as follows: 1. MCAO control group (ischemia without treatment); 2. Vehicle group; 3. Modafinil group that was randomly subdivided into three groups receiving different doses of modafinil (10, 30, and 100 mg/kg) for 7 days before MCAO; 4. Ethanol group receiving 1.5 g/kg ethanol at the time of reperfusion; 5. Modafinil + ethanol group that was further subdivided into three groups receiving modafinil at different doses (10, 30, and 100 mg/kg) for 7 days before MCAO and ethanol at the time of reperfusion. The motor behavior was measured using the Garcia test 24, 48, and 72 h after the ischemia, and the elevated body swing test was performed 48 and 72 h after the ischemia. The anxiety and locomotor activity were analyzed by open field test 48 and 72 h post-ischemia. Results: The results showed that the neurological deficit score, locomotor activity, and unexpected thigmotaxis (anxiety) in the ethanol, modafinil (in a dose-dependent manner), and ethanol+modafinil treatment groups were significantly higher than the MCAO control group. Conclusion: It seems that the combination therapy of modafinil (100 mg/kg) and ethanol (1.5 g/kg) significantly enhanced neuroprotection via an improvement in locomotor activity and neurological functions.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%